ROCHESTER, N.Y. — A nationwide multicenter phase III trial has demonstrated that a structured home-based exercise program may help cancer patients maintain cognitive function and reduce the effects of so-called “chemo brain” during chemotherapy treatment. According to findings published in the JNCCN—Journal of the National Comprehensive Cancer Network and announced by researchers at the University of Rochester’s Wilmot Cancer Institute, the study enrolled 687 patients across 20 community oncology practices who were receiving chemotherapy for the first time. Co-lead authors Dr. Karen M. Mustian and Dr. Po-Ju Lin led the research in collaboration with the National Cancer Institute Community Oncology Research Program Research Base. This article draws upon reporting from PRNewswire, University of Rochester Medical Center, PubMed/NCBI, News-Medical.net, ASCO Post, and Medical Dialogues. Each of the bullet points immediately below have been confirmed by at least four of the six respected sources we curated on this story.
- 687 patients participated in the nationwide, multicenter phase III randomized controlled trial conducted across 20 community oncology practices in the United States
- The Exercise for Cancer Patients (EXCAP) program combined progressive aerobic walking with resistance band exercises in a home-based, individually tailored six-week intervention
- Patients receiving chemotherapy on two-week cycles who followed the exercise prescription reported significantly less overall cognitive impairment compared to those receiving standard care without exercise
- Up to 75% of cancer patients experience cancer-related cognitive impairment, commonly called “chemo brain,” which includes symptoms such as brain fog, memory problems, and difficulty managing daily tasks like medications or finances
- Patients in the exercise group were generally able to maintain their usual daily walking levels during chemotherapy, while those in the standard care group reduced their daily steps by approximately 53%
- The study was conducted through the University of Rochester Cancer Center NCI Community Oncology Research Program Research Base between 2009 and 2014
- Benefits were most pronounced in patients receiving chemotherapy every two weeks, with less significant effects observed in patients on three- to four-week treatment cycles
- Participants used pedometers to track daily steps and maintained diaries of resistance band exercise time as part of the structured program
Additional Details Reported
The EXCAP program was developed by Dr. Karen Mustian in collaboration with American College of Sports Medicine exercise professionals specifically to provide safe, practical, low-cost exercise during chemotherapy. The program uses a “teach-back” method to ensure patients understand proper technique for the walking and resistance band exercises, making it accessible for home use without requiring specialized equipment or gym memberships.
Researchers speculate that the two-week chemotherapy cycle may represent a “sweet spot” for exercise recovery, allowing patients enough time between treatments to maintain physical activity. Patients on longer three- to four-week cycles may experience more toxicity and side effects that make exercise more difficult to sustain. This timing factor suggests that exercise benefits may vary depending on the specific chemotherapy regimen prescribed.
The study also examined inflammatory markers through blood samples, finding that suppressed inflammatory responses were associated with cancer-related cognitive impairment in patients receiving chemotherapy. Exercise-induced immunocompetence, characterized by healthy inflammatory responses involving both proinflammatory and anti-inflammatory cytokines, may help explain the cognitive benefits observed in the exercise group.
Dr. Lindsay L. Peterson, a medical oncologist at Washington University School of Medicine who serves as Chair of the NCCN Clinical Practice Guidelines in Oncology Panel for Survivorship, commented that these findings reinforce the NCCN Guidelines recommendation that survivors with cancer-related cognitive dysfunction engage in routine physical activity. The guidelines also provide detailed safety information to help patients exercise appropriately during and after cancer treatment.
The researchers emphasized that non-pharmacologic interventions such as exercise, cognitive training, and mindfulness are particularly valuable for managing chemo brain because they are safe, accessible, and can often be delivered at low cost or even at home, making them easier for patients to use compared with expensive or clinic-based treatments. Cancer care providers are encouraged to incorporate structured exercise prescriptions into routine chemotherapy care and refer patients to exercise oncology specialists when needed.
Image Attribution
Image: Previously published EOBS stock photo / EOBS.biz
How we report: We select the day’s most important stories, confirm facts across multiple reputable sources, and avoid anonymous sourcing. Our goal is clear, balanced coverage you can trust—because transparency and verification matter for informed readers.